Will Harvard Continue to Lead the Charge? - Part 67

From the Harvard Crimson: Harvard School of Public Health Dean Andrea A. Baccarelli received at least $150,000 to testify against Tylenol’s manufacturer in 2023 — two years before he published research used by the Trump administration to link the drug to autism, a connection experts say is tenuous at best. Baccarelli served as an expert witness on behalf of parents and guardians of children suing Johnson & Johnson, the manufacturer of Tylenol at the time. U.S. District Court Judge Denise L. Cote dismissed the case last year due to a lack of scientific evidence, throwing out Baccarelli’s testimony in the process.

“He cherry-picked and misrepresented study results and refused to acknowledge the role of genetics in the etiology” of autism spectrum disorder or ADHD, Cote wrote in her decision, which the plaintiffs have since appealed...

Full story at https://www.thecrimson.com/article/2025/9/24/autism-dean-public-health/.